Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study Design

Hypertrophic cardiomyopathy (HCM) is the most common congenital disease increasing the risk of sudden cardiac death. For many years, HCM patients were excluded from exercise training. However, there are data showing that patients with HCM undergoing supervised exercise training could improve physica...

Full description

Bibliographic Details
Main Authors: Krzysztof Sadowski, Ryszard Piotrowicz, Mariusz Kłopotowski, Jadwiga Wolszakiewicz, Agnieszka Lech, Adam Witkowski, Edyta Smolis-Bąk, Ilona Kowalik, Anna Mierzyńska, Dorota Piotrowska, Piotr Dobrowolski, Maciej Dąbrowski, Ewa Sadowy, Ewa Piotrowicz
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/10/5046
_version_ 1797501811031015424
author Krzysztof Sadowski
Ryszard Piotrowicz
Mariusz Kłopotowski
Jadwiga Wolszakiewicz
Agnieszka Lech
Adam Witkowski
Edyta Smolis-Bąk
Ilona Kowalik
Anna Mierzyńska
Dorota Piotrowska
Piotr Dobrowolski
Maciej Dąbrowski
Ewa Sadowy
Ewa Piotrowicz
author_facet Krzysztof Sadowski
Ryszard Piotrowicz
Mariusz Kłopotowski
Jadwiga Wolszakiewicz
Agnieszka Lech
Adam Witkowski
Edyta Smolis-Bąk
Ilona Kowalik
Anna Mierzyńska
Dorota Piotrowska
Piotr Dobrowolski
Maciej Dąbrowski
Ewa Sadowy
Ewa Piotrowicz
author_sort Krzysztof Sadowski
collection DOAJ
description Hypertrophic cardiomyopathy (HCM) is the most common congenital disease increasing the risk of sudden cardiac death. For many years, HCM patients were excluded from exercise training. However, there are data showing that patients with HCM undergoing supervised exercise training could improve physical performance without serious adverse events. A project was designed as a randomized clinical trial to assess the effectiveness and safety of hybrid cardiac rehabilitation (HCR)—a combination of hospital-based cardiac rehabilitation (1 month) with a new form of home-based telemonitored cardiac rehabilitation (2 months) in HCM patients without left ventricular (LV) outflow tract obstruction and preserved systolic function. Sixty patients who fulfil the inclusion criteria have been randomly assigned (1:1) to either HCR plus usual care (training group) or usual care only (control group). The primary endpoint is a functional capacity evaluated by peak oxygen uptake (pVO<sub>2</sub>). Secondary endpoints include workload time during the cardiopulmonary exercise testing, a six-minute walk test distance, NT-pro BNP level, echocardiographic parameters of the left ventricular diastolic function (E/A, E/e’, myocardial strain rate), right ventricular systolic pressure, a gradient in the LV outflow tract, and quality of life. The tertiary analysis includes safety, acceptance and adherence to the HCR program. Our research will provide innovative data on the effectiveness and safety of hybrid cardiac rehabilitation in HCM patients without LV outflow tract obstruction and preserved systolic function. Clinical trials registry: ClinicalTrials.gov Identifier NCT03178357.
first_indexed 2024-03-10T03:23:56Z
format Article
id doaj.art-f4acb249a00e463094755aee7f744174
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-10T03:23:56Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-f4acb249a00e463094755aee7f7441742023-11-23T09:57:02ZengMDPI AGApplied Sciences2076-34172022-05-011210504610.3390/app12105046Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study DesignKrzysztof Sadowski0Ryszard Piotrowicz1Mariusz Kłopotowski2Jadwiga Wolszakiewicz3Agnieszka Lech4Adam Witkowski5Edyta Smolis-Bąk6Ilona Kowalik7Anna Mierzyńska8Dorota Piotrowska9Piotr Dobrowolski10Maciej Dąbrowski11Ewa Sadowy12Ewa Piotrowicz13Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Interventional Cardiology and Angiology, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Congenital Heart Diseases, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Interventional Cardiology and Angiology, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Hypertension, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Interventional Cardiology and Angiology, National Institute of Cardiology, 04-628 Warsaw, PolandDepartment of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 04-628 Warsaw, PolandTelecardiology Center, National Institute of Cardiology, 04-628 Warsaw, PolandHypertrophic cardiomyopathy (HCM) is the most common congenital disease increasing the risk of sudden cardiac death. For many years, HCM patients were excluded from exercise training. However, there are data showing that patients with HCM undergoing supervised exercise training could improve physical performance without serious adverse events. A project was designed as a randomized clinical trial to assess the effectiveness and safety of hybrid cardiac rehabilitation (HCR)—a combination of hospital-based cardiac rehabilitation (1 month) with a new form of home-based telemonitored cardiac rehabilitation (2 months) in HCM patients without left ventricular (LV) outflow tract obstruction and preserved systolic function. Sixty patients who fulfil the inclusion criteria have been randomly assigned (1:1) to either HCR plus usual care (training group) or usual care only (control group). The primary endpoint is a functional capacity evaluated by peak oxygen uptake (pVO<sub>2</sub>). Secondary endpoints include workload time during the cardiopulmonary exercise testing, a six-minute walk test distance, NT-pro BNP level, echocardiographic parameters of the left ventricular diastolic function (E/A, E/e’, myocardial strain rate), right ventricular systolic pressure, a gradient in the LV outflow tract, and quality of life. The tertiary analysis includes safety, acceptance and adherence to the HCR program. Our research will provide innovative data on the effectiveness and safety of hybrid cardiac rehabilitation in HCM patients without LV outflow tract obstruction and preserved systolic function. Clinical trials registry: ClinicalTrials.gov Identifier NCT03178357.https://www.mdpi.com/2076-3417/12/10/5046hypertrophic cardiomyopathyexercise trainingrehabilitationtelerehabilitation
spellingShingle Krzysztof Sadowski
Ryszard Piotrowicz
Mariusz Kłopotowski
Jadwiga Wolszakiewicz
Agnieszka Lech
Adam Witkowski
Edyta Smolis-Bąk
Ilona Kowalik
Anna Mierzyńska
Dorota Piotrowska
Piotr Dobrowolski
Maciej Dąbrowski
Ewa Sadowy
Ewa Piotrowicz
Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study Design
Applied Sciences
hypertrophic cardiomyopathy
exercise training
rehabilitation
telerehabilitation
title Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study Design
title_full Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study Design
title_fullStr Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study Design
title_full_unstemmed Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study Design
title_short Efficacy and Safety of Hybrid Cardiac Telerehabilitation in Patients with Hypertrophic Cardiomyopathy without Left Ventricular Outflow Tract Obstruction and Preserved Ejection Fraction—A Study Design
title_sort efficacy and safety of hybrid cardiac telerehabilitation in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction and preserved ejection fraction a study design
topic hypertrophic cardiomyopathy
exercise training
rehabilitation
telerehabilitation
url https://www.mdpi.com/2076-3417/12/10/5046
work_keys_str_mv AT krzysztofsadowski efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT ryszardpiotrowicz efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT mariuszkłopotowski efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT jadwigawolszakiewicz efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT agnieszkalech efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT adamwitkowski efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT edytasmolisbak efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT ilonakowalik efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT annamierzynska efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT dorotapiotrowska efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT piotrdobrowolski efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT maciejdabrowski efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT ewasadowy efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign
AT ewapiotrowicz efficacyandsafetyofhybridcardiactelerehabilitationinpatientswithhypertrophiccardiomyopathywithoutleftventricularoutflowtractobstructionandpreservedejectionfractionastudydesign